NCT05984342 2023-08-09Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell CarcinomaAffiliated Cancer Hospital of Shantou University Medical CollegePhase 1 Recruiting50 enrolled